Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yalei Liu

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 12, 2005
Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonistsAshvinikumar V Gavai, Roy J Vaz, Amarendra B Mikkilineni, et al.
Diabetes Care|October 8, 2021
Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control StudyYuanyuan Fang, Chenhong Zhang, Hongcai Shi, et al.
Diabetes Care|January 12, 2022
Erratum. Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control Study. Diabetes Care 2021;44:2738-2746Yuanyuan Fang, Chenhong Zhang, Hongcai Shi, et al.
Frontiers in Cellular and Infection Microbiology|March 27, 2024
Alteration in gut microbiota is associated with immune imbalance in Graves' diseaseYalei Liu, Shasha Tang, Yu Feng, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2015
Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4BNanjing Zhang, Anthony Turpoff, Xiaoyan Zhang, et al.
Mbio|May 31, 2024
Guild-level signature of gut microbiome for diabetic kidney diseaseShasha Tang, Guojun Wu, Yalei Liu, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2022
Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 DiabetesXinru Deng, Chenhong Zhang, Pengxu Wang, et al.
Steroids|April 10, 2004
Characterization of a new class of selective nonsteroidal progesterone receptor agonistsYu Dong, Jacques Y Roberge, Zhaoqing Wang, et al.
Journal of Combinatorial Chemistry|December 18, 2008
Design and synthesis of a G-protein-coupled receptor antagonist library of aryloxyalkanolamines using a polymer-supported acyclic acetal linkerJacques Y Roberge, Lalgudi S Harikrishnan, Muthoni G Kamau, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4BXiaoyan Zhang, Nanjing Zhang, Guangming Chen, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|October 12, 2005
Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonistsAshvinikumar V Gavai, Roy J Vaz, Amarendra B Mikkilineni, et al.
Diabetes Care|October 8, 2021
Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control StudyYuanyuan Fang, Chenhong Zhang, Hongcai Shi, et al.
Diabetes Care|January 12, 2022
Erratum. Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control Study. Diabetes Care 2021;44:2738-2746Yuanyuan Fang, Chenhong Zhang, Hongcai Shi, et al.
Frontiers in Cellular and Infection Microbiology|March 27, 2024
Alteration in gut microbiota is associated with immune imbalance in Graves' diseaseYalei Liu, Shasha Tang, Yu Feng, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2015
Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4BNanjing Zhang, Anthony Turpoff, Xiaoyan Zhang, et al.
Mbio|May 31, 2024
Guild-level signature of gut microbiome for diabetic kidney diseaseShasha Tang, Guojun Wu, Yalei Liu, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2022
Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 DiabetesXinru Deng, Chenhong Zhang, Pengxu Wang, et al.
Steroids|April 10, 2004
Characterization of a new class of selective nonsteroidal progesterone receptor agonistsYu Dong, Jacques Y Roberge, Zhaoqing Wang, et al.
Journal of Combinatorial Chemistry|December 18, 2008
Design and synthesis of a G-protein-coupled receptor antagonist library of aryloxyalkanolamines using a polymer-supported acyclic acetal linkerJacques Y Roberge, Lalgudi S Harikrishnan, Muthoni G Kamau, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4BXiaoyan Zhang, Nanjing Zhang, Guangming Chen, et al.
Pageof 7